The new development is promising a potential treatment option for patients with chronic heart failure.
There are over six million patients in the U.S. who suffer from chronic heart failure, and now there is a cell therapy that might help all these patients.
They have proposed a treatment called MPC (mesenchymal precursor cell) therapy.
Rasi Bhadramani/iStock.
A team of researchers from the Texas Health Institute (THI) recently published results of the biggest cell therapy trial conducted in 565 heart patients from 51 different cities in the U.S. (also referred to as DREAM HF trials).
Comments are closed.